Article Information
History
- February 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alberto Cedro-Tanda1,+,
- Laura Gómez-Romero1,+,
- Guillermo de Anda-Jauregui1,2,3,+,
- Dora Garnica-López1,
- Yair Alfaro-Mora1,
- Sonia Sánchez-Xochipa1,
- F. Eulices García-García1,
- Alfredo Mendoza-Vargas1,
- J. Emmanuel Frías-Jiménez1,
- Bernardo Moreno-Quiroga1,
- Abraham Campos-Romero4,
- José Luis Moreno-Camacho5,
- Jonathan Alcantar-Fernández6,
- Jesús Ortíz-Ramírez7,
- Mariana Benitez-Gonzalez7,
- Roxana Trejo-Gonzalez8,
- Daniel Aguirre-Chavarria8,
- Marcela E. Núñez-Martínez8,
- Laura Uribe-Figueroa9,
- Ofelia Angulo10,
- Rosaura Ruiz10,
- Alfredo Hidalgo-Miranda1,* and
- Luis A Herrera1,11,*
- 1Instituto Nacional de Medicina Genómica, Mexico City, Mexico
- 2Researchers for Mexico (previously Cátedras CONACYT para jóvenes investigadores), Mexico City, Mexico
- 3Centro de Ciencias de la Complejidad, UNAM, Mexico City, Mexico
- 4Innovation and Research Department, Salud Digna, Sinaloa, Mexico
- 5Clinical Laboratory Division, Salud Digna, Sinaloa, Mexico
- 6Innovation and Research Department, Salud Digna, Sinaloa, Mexico
- 7Hospital General Ajusco Medio, SEDESA, Mexico City, Mexico
- 8Centro Médico ABC, Mexico City, Mexico
- 9Laboratorio Arion Genética, Mexico City, Mexico
- 10Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México
- 11Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM
- ↵*Corresponding authors; ; email: lherrera{at}inmegen.gob.mx.
↵+ These authors contributed equally to this work. The order of the authors was decided in consensus by the three first authors, but this order may be reported differently if it pleases them.
Posted February 07, 2022.
Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City
